- Investing Ideas
- /
- New Zealand Pharmaceuticals & Biotech Strong Balance Sheet Stocks
New Zealand Pharmaceuticals & Biotech Strong Balance Sheet Stocks
UPDATED May 18, 2022
U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CBDCannasouth | NZ$0.34 | 4.5% | -12.7% | NZ$44.6m | n/a | PS36.4x | n/a | n/a | ||
| AFTAFT Pharmaceuticals | NZ$3.10 | -1.6% | -31.9% | NZ$335.2m | NZ$5.88 | PS30.5x | E37.6% | n/a | ||
| RUARua Bioscience | NZ$0.32 | -5.9% | -20.0% | NZ$48.0m | n/a | PB1.8x | n/a | n/a | ||
| PEBPacific Edge | NZ$0.81 | 1.3% | -28.9% | NZ$672.4m | NZ$1.11 | PS57x | E-1.5% | n/a |
Page 1 of 1